2018
DOI: 10.1016/j.jconrel.2018.05.002
|View full text |Cite
|
Sign up to set email alerts
|

Histidine-rich glycoprotein-induced vascular normalization improves EPR-mediated drug targeting to and into tumors

Abstract: Tumors are characterized by leaky blood vessels, and by an abnormal and heterogeneous vascular network. These pathophysiological characteristics contribute to the enhanced permeability and retention (EPR) effect, which is one of the key rationales for developing tumor-targeted drug delivery systems. Vessel abnormality and heterogeneity, however, which typically result from excessive pro-angiogenic signaling, can also hinder efficient drug delivery to and into tumors. Using histidine-rich glycoprotein (HRG) kno… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
28
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 35 publications
(28 citation statements)
references
References 60 publications
0
28
0
Order By: Relevance
“…As an alternative to companion nanodiagnostics and nanotheranostics, clinically established (but intuitively significantly less specific) 'standard' imaging protocols could be considered to predict the accumulation and efficacy of passively targeted cancer nanomedicines, such as dynamic contrast-enhanced MRI 39 , CT 40 and ultrasound 41 . Furthermore, future analyses should set out to evaluate if histopathological assessment of tumour biopsies can help to stratify responders from non-responders.…”
Section: Imaging Biomarkersmentioning
confidence: 99%
“…As an alternative to companion nanodiagnostics and nanotheranostics, clinically established (but intuitively significantly less specific) 'standard' imaging protocols could be considered to predict the accumulation and efficacy of passively targeted cancer nanomedicines, such as dynamic contrast-enhanced MRI 39 , CT 40 and ultrasound 41 . Furthermore, future analyses should set out to evaluate if histopathological assessment of tumour biopsies can help to stratify responders from non-responders.…”
Section: Imaging Biomarkersmentioning
confidence: 99%
“…The direct permeability enhancement by various methods has been explored that take advantage of the EPR effect and facilitate the delivery of drugs/macromolecules inside tumors. Examples include the selective inhibition of angiotensin-converting enzymes [ 86 , 87 ], generation of NO or CO within tumors [ 56 , 87 , 88 ], blockage of VEGF and other angiogenic signaling factors [ 89 , 90 , 91 ], inhibition of pericyte recruitment and BM activation [ 92 , 93 ], and image guiding systems [ 94 ].…”
Section: Strategies To Overcome Heterogeneitymentioning
confidence: 99%
“…Thus, the FMT/CT technique in combination with targeted imaging might become a promising tool for assessments of an early therapeutic response. Recently, HPMA polymer conjugates labelled by fluorophores ATTO 488-NH 2 and Dy750-NH 2 were employed to show that normalizing the tumour vasculature improves the accumulation of polymer carriers in tumours, and promotes their penetration out of tumour blood vessels deep into the interstitium [125].…”
Section: Fluorescence-based Tomography and Future Prospectsmentioning
confidence: 99%